HHS & Healthcare Contracts Intelligence — September 03, 2026

Walgreens secured a competitively awarded, firm-fixed-price contract from the CDC for specialized medical support, providing $290.9 million in fully obligated revenue through May 2025, representing roughly $96.9 million per year in near-term revenue visibility.

The firm-fixed-price structure exposes Walgreens to cost overrun risk if the specialized medical support services under ICATT exceed budgeted costs, potentially compressing margins on this fully obligated contract.

This single contract represents a large, fully obligated civilian award for Walgreens, creating revenue concentration risk if the contract is not renewed or if competitor CDC contracts shift market share.

ICATT program funding is subject to CDC budget appropriations; any CR or budget cuts in FY2025-2026 could delay or reduce follow-on awards or renewal options.

Walgreens' competitive win positions it for potential follow-on ICATT awards or expansion into other CDC specialized medical support contracts, as the agency continues to fund pandemic preparedness and public health infrastructure.

The $290.9 million Walgreens award reflects sustained CDC spending on specialized medical support services, even as broader federal budget uncertainty persists, suggesting healthcare response contracts remain a durable civilian spending area.

{"entity" => "Walgreens Boots Alliance (WBA)", "reason" => "Holder of a $290.9M fully obligated CDC contract with medium execution risk under fixed-price terms", "trigger" => "WBA Q2 2025 earnings call for cost commentary; CDC ICATT program budget updates in FY2025-2026"}

{"entity" => "CVS Health", "reason" => "Potential competitor for CDC specialized medical support contracts; any new CDC awards to CVS would signal market share shifts away from Walgreens", "trigger" => "Announcement of any CDC ICATT-related task order or contract award to CVS Health"}

{"entity" => "CDC (HHS)", "reason" => "Key contract counterparty; any budget cuts or restructuring of the ICATT program would directly impact Walgreens' revenue visibility", "trigger" => "FY2025 HHS budget request; re-compete or option exercise announcements for ICATT"}